EyePoint Pharmaceuticals
EYPT
#5241
Rank
$1.47 B
Marketcap
$17.78
Share price
-0.25%
Change (1 day)
100.85%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -$0.22 Billion USD

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are $42.34 Million USD. In 2024 the company made an earning of -$0.14 Billion USD a decrease over its 2023 earnings that were of -$69.47 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.22 Billion54.76%
2024 -$0.14 Billion99.41%
2023 -$69.47 Million-29.88%
2022 -$99.07 Million87.2%
2021 -$52.92 Million38.58%
2020 -$38.19 Million-24.56%
2019 -$50.62 Million
2017 -$23.09 Million22.59%
2016 -$18.84 Million-8.02%
2015 -$20.48 Million-296.09%
2014 $10.44 M-174.02%
2013 -$14.11 Million37.42%
2012 -$10.27 Million-56.29%
2011 -$23.49 Million-1062.38%
2010 $2.44 M-250.43%
2009 -$1.63 Million-89.5%
2008 -$15.46 Million
2005 -$9.53 Million56.99%
2004 -$6.07 Million73.7%
2003 -$3.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NRC Health
NRC
$27.57 M-112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-$2.17 Million-98.99% Bahamas